Complement receptor 4 mediates the clearance of extracellular tau fibrils by microglia
The FEBS Journal · 2024-08 · 291 (15) · 3499-3520
DOI: 10.1111/febs.17150 ↗At a glance
Journal article in The FEBS Journal, published online on 2024-05-07. Written by Chang Jae Yoo and 6 co-authors. Institution: Dementia Research Group, Korea Brain Research Institute (KBRI), Daegu, South Korea. Major MEDLINE topics: Microglia, tau Proteins. Cited 15 times so far (Crossref); 117 references. Funded by: Ministry of Health & Welfare and Ministry of Science and ICT, Ministry of Science and ICT, South Korea, Korea Health Technology R&D Project.
Abstract (original language)
Tauopathies exhibit a characteristic accumulation of misfolded tau aggregates in the brain. Tau pathology shows disease‐specific spatiotemporal propagation through intercellular transmission, which is closely correlated with the progression of clinical manifestations. Therefore, identifying molecular mechanisms that prevent tau propagation is critical for developing therapeutic strategies for tauopathies. The various innate immune receptors, such as complement receptor 3 (CR3) and complement receptor 4 (CR4), have been reported to play a critical role in the clearance of various extracellular toxic molecules by microglia. However, their role in tau clearance has not been studied yet. In the present study, we investigated the role of CR3 and CR4 in regulating extracellular tau clearance. We found that CR4 selectively binds to tau fibrils but not to tau monomers, whereas CR3 does not bind to either of them. Inhibiting CR4, but not CR3, significantly reduces the uptake of tau fibrils by BV2 cells and primary microglia. By contrast, inhibiting CR4 has no effect on the uptake of tau monomers by BV2 cells. Furthermore, inhibiting CR4 suppresses the clearance of extracellular tau fibrils, leading to more seed‐competent tau fibrils remaining in the extracellular space relative to control samples. We also provide evidence that the expression of CR4 is upregulated in the brains of human Alzheimer's disease patients and the PS19 mouse model of tauopathy. Taken together, our data strongly support that CR4 is a previously undescribed receptor for the clearance of tau fibrils in microglia and may represent a novel therapeutic target for tauopathy.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Dementia Research Group, Korea Brain Research Institute (KBRI), Daegu, South Korea.
- Department of Brain Sciences, Daegu Gyeongbuk Institute of Science & Technology (DGIST), South Korea.
- Research Center for Bioconvergence Analysis, Korea Basic Science Institute (KBSI), Ochang, South Korea.
- Bio-Analytical Science, University of Science and Technology, Daejeon, South Korea.
- Graduate School of Analytical Science and Technology, Chungnam National University, Daejeon, South Korea.
- Department of Systems Biotechnology, Chung-Ang University, Anseong-si, South Korea.
ORCID profiles: Jaekwang Kim
Funding
- Ministry of Health & Welfare and Ministry of Science and ICT
- Ministry of Science and ICT, South Korea
- Korea Health Technology R&D Project
- Korea Government (MSIT)
- KBSI Fund
- Korean Government
Cite
APA
Yoo, C. J., Choi, Y., Bok, E., Lin, Y., Cheon, M., Lee, Y. H., & Kim, J. (2024). Complement receptor 4 mediates the clearance of extracellular tau fibrils by microglia. The FEBS Journal, 291(15), 3499-3520. https://doi.org/10.1111/febs.17150
Vancouver
Yoo CJ, Choi Y, Bok E, Lin Y, Cheon M, Lee YH, et al. Complement receptor 4 mediates the clearance of extracellular tau fibrils by microglia. The FEBS Journal. 2024;291(15):3499-3520. doi:10.1111/febs.17150
BibTeX
@article{Yoo2024,
author = {Yoo, Chang Jae and Choi, Youngtae and Bok, Eugene and Lin, Yuxi and Cheon, Mookyung and Lee, Young-Ho and Kim, Jaekwang},
title = {Complement receptor 4 mediates the clearance of extracellular tau fibrils by microglia},
journal = {The FEBS Journal},
year = {2024},
volume = {291},
number = {15},
pages = {3499--3520},
doi = {10.1111/febs.17150}
}
EUVIMED